CWP
GILD icon

Concord Wealth Partners’s Gilead Sciences GILD Stock Holding History

Concord Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-45
Closed -$5K – 870
2025
Q3 		$5K Sell
45
-530
-92% -$60.2K ﹤0.01% 622
2025
Q2 		$63.8K Sell
575
-591
-51% -$62.9K 0.01% 315
2025
Q1 		$131K Sell
1,166
-8,209
-88% -$847K 0.02% 221
2024
Q4 		$866K Buy
9,375
+6,194
+195% +$558K 0.14% 112
2024
Q3 		$267K Sell
3,181
-202
-6% -$15.4K 0.04% 183
2024
Q2 		$232K Sell
3,383
-16,533
-83% -$1.1M 0.04% 183
2024
Q1 		$1.46M Buy
19,916
+1,561
+9% +$120K 0.26% 78
2023
Q4 		$1.49M Buy
18,355
+4,684
+34% +$364K 0.3% 72
2023
Q3 		$1.02M Buy
13,671
+4,376
+47% +$337K 0.22% 78
2023
Q2 		$716K Buy
9,295
+4,290
+86% +$342K 0.15% 88
2023
Q1 		$415K Buy
5,005
+4,615
+1,183% +$382K 0.12% 94
2022
Q4 		$33.5K Buy
+390
New +$30.9K 0.01% 448
2022
Q3 		– Sell
-694
Closed -$43K – 533
2022
Q2 		$43K Sell
694
-1,603
-70% -$99.2K 0.01% 398
2022
Q1 		$137K Buy
2,297
+152
+7% +$9.72K 0.04% 241
2021
Q4 		$156K Buy
2,145
+1,901
+779% +$131K 0.04% 223
2021
Q3 		$17K Sell
244
-1,225
-83% -$86.1K 0.01% 402
2021
Q2 		$101K Buy
1,469
+424
+41% +$28.3K 0.03% 235
2021
Q1 		$68K Buy
1,045
+1,027
+5,706% +$66.2K 0.02% 280
2020
Q4 		$1K Buy
+18
New +$1.09K ﹤0.01% 622

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Concord Wealth Partners's GILD Position: Q4 2025 in Review

Concord Wealth Partners sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 45 shares — an estimated $5K sold.

Concord Wealth Partners first reported a position in GILD in Q4 2020 and held it in 19 quarters. The position peaked at $1.49M in Q4 2023. 2,220 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Concord Wealth Partners reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Concord Wealth Partners sold 45 Gilead Sciences shares in Q4 2025, an estimated $5K.
  • Concord Wealth Partners first reported a position in Gilead Sciences in Q4 2020 and held it in 19 quarters.
  • Concord Wealth Partners's Gilead Sciences position peaked at $1.49M in Q4 2023.
  • 2,220 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Concord Wealth Partners's 13F filing for Q4 2025, filed 29 Jan 2026.